製品の概要

  • 製品名
    Anti-WASF3 antibody
  • 製品の詳細
    Rabbit polyclonal to WASF3
  • アプリケーション
    適用あり: ELISA, IHC-Pmore details
  • 種交差性
    交差種: Mouse, Human
  • 免疫原

    Synthetic peptide derived from an internal region of Human WASF3.

  • ポジティブ・コントロール
    • Human breast carcinoma tissue

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab110739 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
ELISA 1/10000.
IHC-P 1/50 - 1/100. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

ターゲット情報

  • 機能
    Downstream effector molecules involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton.
  • 組織特異性
    Expressed in ovary and brain.
  • 配列類似性
    Belongs to the SCAR/WAVE family.
    Contains 1 WH2 domain.
  • ドメイン
    Binds the Arp2/3 complex through the C-terminal region and actin through verprolin homology (VPH) domain.
  • 細胞内局在
    Cytoplasm > cytoskeleton.
  • Information by UniProt
  • 参照データベース
  • 別名
    • KIAA0900 antibody
    • Protein WAVE-3 antibody
    • Protein WAVE3 antibody
    • SCAR3 antibody
    • Verprolin homology domain containing protein 3 antibody
    • Verprolin homology domain-containing protein 3 antibody
    • WASF3 antibody
    • WASF3_HUMAN antibody
    • WASP family protein member 3 antibody
    • WAVE3 antibody
    • Wiskott Aldrich syndrome protein family member 3 antibody
    • Wiskott-Aldrich syndrome protein family member 3 antibody
    see all

Anti-WASF3 antibody 画像

  • Immunohistochemistry analysis of paraffin-embedded Human breast carcinoma tissue using ab110739 at a dilution of 1/50. Right panel was also treated with blocking peptide.

プロトコール

Anti-WASF3 antibody (ab110739) 使用論文

This product has been referenced in:
  • Wu J  et al. Expression of WASF3 in patients with non-small cell lung cancer: Correlation with clinicopathological features and prognosis. Oncol Lett 8:1169-1174 (2014). IHC-P ; Human . Read more (PubMed: 25120680) »

See 1 Publication for this product

Product Wall

There are currently no Abreviews or Questions for ab110739.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"

登録